Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences
  • Register
  • Login

Urology Journal

  • Home
  • Instant Online
    • Instant 2026
    • Instant 2023
    • Instant 2021
    • Instant 2020
  • Current
  • Archives
  • Announcements
  • Submissions
  • Author Guidelines
  • About
    • About the Journal
    • Editorial Team
    • Privacy Statement
    • Contact
Advanced Search
  1. Home
  2. Archives
  3. Vol. 15 No. 3 (2018): May-June2018
  4. CASE REPORT

Vol. 15 No. 3 (2018)

May 2018

Mesalazine: A Novel Etiology For Drug-Induced Urinary Calculi

  • Blaise Corbery
  • Souhil Lebdai
  • Shahed Borojeni
  • Pierre Bigot
  • Abdel-Rahmène Azzouzi
  • Thibaut Culty

Urology Journal, Vol. 15 No. 3 (2018), 3 May 2018 , Page 132-133
https://doi.org/10.22037/uj.v15i3.3902 Published: 2018-05-03

  • View Article
  • Download
  • Cite
  • References
  • Statastics
  • Share

Abstract

We report the case of a 23-year-old woman treated by mesalazine for ulcerative colitis and who subsequently presented recurrent renal colic due to mesalazine urinary stones. This is the second case described in the literature.
Mesalazine stones are soft, friable and have an orange-beige color. They are not visible on non-contrast computed tomography (CT). Their diagnosis is based on morpho-constitutional analysis and CT-urography. Patients treated
by mesalazine who present renal colic should undergo CT-urography in order to make the diagnosis.
  • PDF

How to Cite

Corbery, B., Lebdai, S., Borojeni, S., Bigot, P., Azzouzi, A.-R., & Culty, T. (2018). Mesalazine: A Novel Etiology For Drug-Induced Urinary Calculi. Urology Journal, 15(3), 132–133. https://doi.org/10.22037/uj.v15i3.3902
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

References

[No authorlisted]. Vidal 2017: The Dictionary. 93th ed. Issy-les-Moulineaux: VIDAL France; 2017:2114-7.

Watanabe M, Nishino H, Sameshima Y, Ota A, Nakamura S, Hibi T. Randomised clinical trial: evaluation of the efficacy of mesalazine

(mesalamine) suppositories in patients with ulcerative colitis and active rectal inflammation -- a placebo-controlled study. Aliment Pharmacol Ther. 2013;38:264-73.

Klotz U, Maier KE. Pharmacology and pharmacokinetics of 5-aminosalicylic acid. Dig Dis Sci. 1987;32:46S-50S.

Gisbert JP, Gonzalez-Lama Y, Mate J. 5-Aminosalicylates and renal function in inflammatory bowel disease: a systematic review. Inflamm Bowel Dis. 2007;13:629-38.

Sacks A, Davis MK. A curious case of redbrown urine in a child taking mesalamine. J Pediatr Gastroenterol Nutr. 2013;56:e38-9.

Jacobsson H, Eriksen J, Karlen P. Mesalazineinduced renal calculi. Am J Case Rep. 2013;14:551-3.

Daudon M, Traxer O, Lechevallier E, Saussine C. [Epidemiology of urolithiasis]. Prog Urol. 2008;18:802-14.

Hess B. Drug-induced urolithiasis. Curr Opin Urol. 1998;8:331-4.

Daudon M. [Drug-induced urinary calculi in 1999]. Prog Urol. 1999;9:1023-33.

De Koninck AS, Groen LA, Maes H, Verstraete AG, Stove V, Delanghe JR. An Unusual Type of Kidney Stone. Clin Lab. 2016;62:235-9.

Schwartz BF, Schenkman N, Armenakas NA, Stoller ML. Imaging characteristics of indinavir calculi. J Urol. 1999;161:1085-7.

Vasanth P, Parmley M, Torrealba J, Hamdi T. Interstitial Nephritis in a Patient with Inflammatory Bowel Disease. Case Rep Nephrol. 2016;2016:4260365.

Mehta RL, Awdishu L, Davenport A, et al. Phenotype standardization for drug-induced kidney disease. Kidney Int. 2015;88:226-34.

  • Abstract Viewed: 1509 times
  • PDF Downloaded: 819 times

Download Statastics

  • Linkedin
  • Twitter
  • Facebook
  • Google Plus
  • Telegram

Information

  • For Readers
  • For Authors

Developed By

Open Journal Systems
  • Home
  • Archives
  • Submissions
  • About the Journal
  • Editorial Team
  • Contact
Powered by OJSPlus